Skip to main content
. 2023 Oct 28;11(11):2653. doi: 10.3390/microorganisms11112653

Figure 3.

Figure 3

Cell-based studies against PAX5VIM-2. (a) Single-dose inhibition assays were performed for 18 h. Amoxicillin and augmentin were used as controls, and the compounds were treated in combination with augmentin. All tests were triplicated. (b) Toxicity values of Augmentin+quercetin analogues and of quercetin analogues alone against human kidney cell lines. a quercetin analogs in combination with augmentin. b quercetin analogs alone. * Augmentin was 25 µM amoxicillin and 12.5 µM clavulanate (2:1 ratio) and was tested against HEK293Twt cells.